Purpose/Aim of the study: To explore the possible role of vascular adhesion protein-1 (VAP-1) via its enzymatic function as a semicarbazide-sensitive amine oxidase (SSAO) in the pathogenesis of proliferative diabetic retinopathy (PDR). 
Introduction
Diabetic retinopathy (DR) is a major microvascular complication of diabetes and a leading cause of blindness among people of working age in developed countries. 1, 2 To date, preclinical and clinical studies have shown that vascular endothelial growth factor (VEGF), a potent angiogenic factor, plays a central role in the two main manifestations of DR, i.e. proliferative diabetic retinopathy (PDR) 3, 4 and diabetic macular edema. (DME) 5, 6 However, recent studies have also elucidated that, in addition to dysregulation of vascular homeostasis caused by VEGF, chronic inflammation and oxidative stress participate in the pathogenesis of DR, particularly at the early stage of this disease. 7, 8 Vascular adhesion protein-1 (VAP-1) is a homodimeric sialylated glycoprotein expressed in vascular endothelial cells and involved in the transmigration step of leukocyte trafficking. 9, 10 A previous study using animal model of early DR revealed that leukocytes adhering to the endothelium damage the endothelial cells of retinal vessels. 11 Our prior research indicates that VAP-1 is expressed in the vascular endothelial cells of fibrovascular tissues in patients with PDR 12 and VAP-1 blockade, furthermore, has been shown to suppress the accumulation of inflammatory cells in DR animal models. 13 Therefore, we had hypothesized that VAP-1 was involved in the pathogenesis of DR via its function as an adhesion molecule, and that it recruited inflammatory cells to the diabetic retina. However, subsequent analyses revealed that the levels of the soluble form of VAP-1 (sVAP-1) are higher in the vitreous fluid 12 and serum 14 of patients with DR. In addition to its role as an adhesion molecule, VAP-1 is also known to have enzymatic function as a semicarbazide-sensitive amine oxidase (SSAO) that converts primary amines to their corresponding aldehydes, releasing hydrogen peroxide and ammonia. 15 These findings led us to hypothesize that VAP-1 acts in the pathogenesis of DR not only as an adhesion molecule, but also as an oxidative enzyme, SSAO.
Acrolein (ACR) is a highly reactive unsaturated aldehyde and reacts preferentially with Cys, Lys, and His residues on the protein with preserving the aldehyde functionality. 16, 17 It is an exogenous pollutant that has been linked to the development of pulmonary disorders; however, recently it has been shown that ACR is also produced endogenously as a consequence of polyamine metabolism, mediated by polyamine oxidases, 18 resulting in cell toxicity and oxidative stress. In the eye, the levels of polyamines in eyes with PDR patients have also been shown to be elevated. 19 Previous studies demonstrated that ACR-conjugated protein, Nε- (3- formyl-3,4-dehydropiperidino) lysine adduct (FDP-Lys), markedly increased in glial cells of diabetic retina, and the FDP-lysine accumulation in the retina was significantly prevented by pyridoxamine, potent antioxidant, of diabetic rats. 20, 21 In addition to the previous studies, we also reported that the FDP-Lys accumulates in cellular components of fibrovascular tissues, i.e., endothelial cells, glial cells and pericytes, obtained from patients with PDR. 22 Therefore, accumulating evidence indicates that sVAP-1/SSAO is associated with the production of ACR as an enzyme that catabolizes polyamine in DR. However, whether sVAP-1/SSAO, similar to polyamine oxidases, catalyzes spermine oxidation and produces ACR in eyes with DR remains unclear.
In this study, we explored the link between sVAP-1/SSAO and ACR in the pathogenesis of DR.
Materials and Methods
Acrolein Production by VAP-1/SSAO.
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Specimens
Vitreous fluid samples were collected from the eyes of 12 patients with PDR (7 
Enzyme-Linked Immunosorbent Assay (ELISA)
The levels of the ACR-conjugated protein, FDP-Lys, were measured using a competitive ELISA kit (MK-150, Takara Bio, Shiga, Japan), according to the manufacturer's protocol. The protein levels of sVAP-1/SSAO in the samples were measured using an ELISA kit for human sVAP-1/SSAO (BMS259, Thermo Fisher Scientific, Waltham, MA). The vitreous samples were pre-diluted to 1:10 by assay buffer and the diluted samples (100µL) were used for sVAP-1/SSAO measurement.
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Immunofluorescence Microscopy
After microwave-based antigen retrieval, paraffin sections were incubated in 10% fluorescence microscope (BIOREVO, BZ-9000, Keyence, Japan).
Cell Culture
The rat retinal capillary endothelial cell line, TR-iBRB2, was provided by Fact Inc.
(Sendai, Japan) 24 . TR-iBRB2 cells were cultured in type I collagen-coated 96-well plates with DMEM containing 5.5mM glucose (normal blood glucose concentration), L-glutamine supplemented with 10% (v/v) FBS, and 15mg/L endothelial cell growth factor (ECGF, Roche, Mannheim, Germany).
Measurement of Hydrogen Peroxide and FDP-Lys Production
Cells 
VAP-1/SSAO Overexpression in Cultured Microvascular Endothelial Cells
The rat Vap-1 cDNA open reading flame (NM_031582.2) was cloned into pcDNA3.1/V5-HIS-C (Thermo Fisher Scientific) using standard cloning techniques.
Rat Vap-1-pcDNA3.1/V5-HIS-C or Mock-pcDNA3.1/V5-HIS-C was transfected into TR-iBRB2 cells using X-treme Gene-HP (Roche).
Western Blotting
Cell lysates were sonicated 3 times for 5 sec each on ice, and centrifuged at 15000g at 4°C for 10 min. The protein concentration was measured using a BCA protein assay kit (Thermo Fisher Scientific) and adjusted to 2mg/mL. The samples were boiled at 95°C for 3 min, separated by SDS-PAGE, and electroblotted to polyvinylidene fluoride (PVDF) membranes (Merck Millipore, Darmstadt, Germany).
Membranes were incubated with 5% skim milk for blocking, then incubated with a rabbit polyclonal antibody against VAP-1/SSAO (1/1000, ab42885, Abcam) at 4°C
overnight, and then finally incubated with goat anti-rabbit IgG (H+L) HRP conjugate
(1:4000; Promega) at room temperature for 1 h. Signals were visualized using a
Supersignal west pico chemiluminescent substrate (Thermo Fisher Scientific).
SSAO Activity Assay
Transfected cells were washed twice with serum-free DMEM and stimulated with rat recombinant TNF-α (0.1 to 1ng/mL, Peprotech) for 17 h. The cells were then incubated with 250µM benzylamine at 37°C for 2 h. Since benzylamine is a substrate for both SSAO and MAO-B, the cells were pretreated with 0.5mM pargylin, a MAO-B inhibitor, for 30 min. SSAO activity in the supernatant was measured using a Fluoro SSAO kit (Cell technology).
Measurement of FDP-Lys Production in Cultured Microvascular

Endothelial Cells overexpressing VAP-1/SSAO
Transfected cells were washed twice with serum-free DMEM and stimulated with rat recombinant TNF-α (0.1 to 1ng/mL, Peprotech) for 17 h. The cells were then Acrolein Production by VAP-1/SSAO. Murata et al. incubated with 200µM spermine and 1mg/mL human serum albumin in PBS at 37°C.
The level of FDP-Lys in the supernatant was determined using an ELISA kit (MK-150, Takara Bio).
Glutathione (GSH) Assay
Recombinant humanVAP-1/SSAO (Peprotech) was incubated with 2.5mM spermine in serum-free DMEM for 24 h. TR-iBRB2 cell was serum-starved and exposed to either pre-incubated mixture of rhVAP-1/SSAO with spermine or ACR ranging from 0 to 100µM for 3 h. Total GSH levels were measured using a total GSH assay kit (Nikken Seil Co., Ltd., Shizuoka, Japan), according to the manufacturer's protocol.
Cell Counting Assay
TR-iBRB2 cells were serum-starved for 17 h and then exposed to ACR. The number of viable cells were counted using 0.4% Trypan blue (Sigma) 24 h after stimulation with concentrations of ACR ranging from 0 to 100µM.
Reactive Oxygen Species (ROS) Detection Assay
Recombinant humanVAP-1/ SSAO (Peprotech) was incubated with 2.5mM spermine in serum free DMEM for 24 h. TR-iBRB2 cells were serum-starved for 17 h and exposed to the either pre-incubated mixture of rhVAP-1/SSAO with spermine or ACR ranging from 0 to 100µM for 24 h. Cellular oxidative stress status was measured by using DCFDA-Cellular ROS Detection Assay Kit (Abcam), according to the manufacturer's protocol.
Statistical Analysis
All results are presented as the mean ± SEM as indicated. The Mann-Whitney U Test was used for statistical comparisons between groups, and one-way ANOVA, with a Tukey-Kramer test, was used for multiple comparisons. Differences in the means were considered statistically significant if the probability values were <0.05.
Spearman's correlation coefficient was used in correlation analyses. 
Results
Accumulation of the ACR-Conjugated
Specificity of the VAP-1/SSAO Inhibitor
To examine the specificity of the novel VAP-1/SSAO inhibitor RTU-1096, we quantified VAP-1/SSAO enzymatic activity in a radiochemical assay. In this assay, showed an IC 50 of 0.9nM against human VAP-1/SSAO, while its IC 50 against human MAO-A and -B were more than 100µM (Fig. 2) . The data indicates the specific Firstly, we compared four types of buffer solutions, and found that PBS is the optimal buffer for the enzymatic reaction of VAP-1/SSAO with spermine (Fig. 3A) .
The production of hydrogen peroxide was both dose-dependent (n=3 each, Fig. 3B) and time-dependent (n=3 each, Fig. 3C ), and the reaction was suppressed by the addition of semicarbazide or the VAP-1 specific inhibitor, RTU-1096 (Fig. 3BC) .
Furthermore, the production of FDP-Lys increased when rhVAP-1/SSAO was incubated with spermine, and was abrogated by semicarbazide or RTU-1096 (n=3 to 5, Fig. 4AB ).
Production of FDP-Lys and Hydrogen Peroxide Mediated by VAP-
1/SSAO Enzymatic Activity in Retinal Microvascular Endothelial Cells
Immunofluorescence microscopy showed that VAP-1/SSAO staining was confined to the cytoplasm of vascular components including endothelial cells of the fibrovascular tissues obtained from patients with PDR (Fig. 5) . Furthermore, FDP-Lys was found to be ubiquitous in the cytoplasm of these cellular components, and co-localized with 
Cell Toxicity of FDP-Lys in Retinal Microvascular Endothelial Cells
To investigate the impact of ACR on endothelial cells, the intracellular GSH levels and cell numbers were measured after ACR stimulation. The GSH levels reduced (n=4 each, P<0.05, Fig. 7A ) and ROS activity increased in the TR-iBRB2 cells with stimulation of ACR in a dose-dependent manner (n=5 each, P<0.01, Fig. 7B ).
Furthermore, the number of viable cells was decreased when stimulated with 100µM ACR (n=4 each, P<0.01, Fig. 7C ).
In accord with the in vitro incubation experiment, the TR-iBRB2 cells stimulated with pre-incubated mixture of rhVAP-1/SSAO with spermine also showed the reduced GSH level (n=3 each, P<0.01, Fig. 7D ) and increased ROS activity (n=5 each, P<0.01, Fig. 7E ).
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Discussion
In the present study, we show that the levels of the ACR-conjugated protein, FDP- In previous studies, we have shown that the levels of sVAP-1/SSAO are higher in the vitreous fluid samples of patients with PDR when compared with those from non-diabetic patients. 12 Consistent with the results, we found the protein levels of sVAP-1/SSAO were higher in patients with PDR than in individuals without diabetes in this study. Furthermore, we found that vitreous fluid ACR-conjugated protein levels were elevated, in correlation with the increased sVAP-1/SSAO levels, in PDR patients, indicating that sVAP-1 acts as an SSAO and generates ACR in eyes with DR.
Polyamines are low molecular weight polycations that have two or more primary amino groups, and are known to play an important role in cell proliferation and differentiation. 25 In mammals, there are three naturally occurring polyamines:
putrescine, spermidine, and spermine. 26 Since putrescine, the precursor used for biosynthesis of the other two polyamines, and urea cycle enzymes that catalyze Acrolein Production by VAP-1/SSAO. Murata et al. polyamines are ubiquitously present in all tissues, polyamines are systemically distributed. 27 In patients with PDR, the levels of spermine have been shown to be up to 15-times higher in vitreous fluid when compared to those of non-DR patients. 19 As mentioned, sVAP-1/SSAO is known to convert primary amines to the corresponding aldehydes with the release of hydrogen peroxide and ammonia. 15 In patients with severe renal failure, the toxic compound ACR is produced in high concentrations from spermidine and spermine by amine oxidase, an enzyme that is inhibited by semicarbazide. 28 Prior evidence has suggested that the amine oxidase activity of VAP-1/SSAO is involved in the generation of ACR via the oxidation of spermine in the eyes of patients with PDR. In the current study, we demonstrate that VAP- Therefore, it is possible that TNF-α induced the release of sVAP-1/ SSAO into the culture media and in the vitreous of PDR eyes, leading to an increase in the reaction frequency of sVAP-1/SSAO and its substrate spermine. However, it is also possible that increased vitreous level of sVAP-1 is due to the hyperpermeability of retinal vessels caused by VEGF in eyes with PDR, since break down of blood-retina-barrier by inflammatory cytokines including VEGF causes serum component influx into the vitreous and elevation of protein concentration in PDR eyes. 31, 32 In addition to the influx of serum ACR and its adduct FDP-Lys, it is likely that sVAP-1/SSAO contributes to production of ACR through spermine oxidation, leading to FDP-Lys accumulation in the vitreous of PDR patients.
The role of oxidative stress in the pathogenesis of DR has been extensively examined in experimental and clinical studies. The levels of various ROS, including superoxide 33 and hydrogen peroxide, 34 have been shown to be elevated in the retinas of diabetic animals, and the antioxidant defense systems in the eyes of patients with DR have been shown to be functionally damaged. 7 Furthermore, ACR and its adduct FDP-Lys have been shown to covalently bind to thiols, such as GSH. 16, 17 Our results agree with those of the previous studies, and show that ACR stimulation reduces the intracellular reserves of GSH, and causes cell death in retinal microvascular endothelial cells. Furthermore, our data indicate that generation of ACR and/or FDP-Lys via spermine oxidation by VAP-1/SSAO deteriorate oxidative stress environment through limiting the defense system against oxidative stress as well as ROS generation.
We recently reported that the thickening of the outer nuclear layer caused by laser photocoagulation was abrogated by oral administration of RTU-1096, 35 also used in the current study. In the previous study, it was demonstrated that laser photocoagulation caused upregulation of the leukocyte adhesion molecules, intercellular adhesion molecule-1 (ICAM-1), and infiltration of inflammatory cells at the vitreoretinal surface, both of which were suppressed by RTU-1096 administration. Since oxidative hydrogen peroxide is known to augment ICAM-1 expression in endothelial cells, 36, 37 it is possible that hydrogen peroxide generation mediated by VAP-1/SSAO plays a role in the response caused by laser photocoagulation.
The limitations of the current study are as follows. First, the concentrations of sVAP-1 protein used for in vitro study were higher than concentrations measured in vitreous fluid of human samples, while the current data demonstrated that spermine was also an exogenous substrate for SSAO. Second, the current study did not include experimental animal data to support the findings of in vitro experiments.
Additional research is needed to obtain the detailed information about spermine oxidation by sVAP-1/SSAO.
In conclusion, our results show that the amine oxidase activities of sVAP- 
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